MustaqeemASiddiquiMDMBA

PubMed

• 3 citations
  Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy.
  Mohammad Ebraheem, Shaji K Kumar, Angela Dispenzieri, Dragan Jevremovic, Francis K Buadi
  Transplantation and Cellular Therapy. 2022-11-01
• 22 citations
  Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma.
  Joselle Cook, Kah-Whye Peng, Thomas E Witzig, Stephen M Broski, Jose C Villasboas
  Blood Advances. 2022-06-14
• 5 citations
  Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).
  Jacqui-Lyn Saw, M Hasib Sidiqi, Michael Ruff, Sara Hocker, Hassan Alkhateeb
  Blood Cancer Journal. 2022-04-13

Abstracts/Posters

• A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
  Mustaqeem Siddiqui, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
  Mustaqeem Siddiqui, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis
  Mustaqeem Siddiqui, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life
  Mustaqeem Siddiqui, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma
  Mustaqeem Siddiqui, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
  Mustaqeem A. Siddiqui, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all